China on this Thursday on this Thursday announced that it has granted market approval attached with conditions for its first homemade COVID-19 vaccine, which was developed by Sinopharm, marking a monumental step in the battle against the pandemic that has killed 1.79 million globally.
Beijing Biological Products Institute announced that the vaccine showed 79.34 percent efficacy and a 99.52 percent antibody positive conversion rate, according to interim results of the Phase III clinical trials.
Subsequently, the persistence and protective effect of vaccine immunity need to be continuously observed.The hard-won achievement build confidence for the global fight against the epidemic and also provides strong support for vaccines to become a global public production.
Related Posts
Q/Ans: 5 Major Queries of International Students in China
Special Report on School Reopening in China in April
Some successful foreigners in China! Work hard and take the opportunities in China!
China lastly accepts "we are likely to reopen to world in first half of 2022"
International students in China commemorate Wuhan restart Anniversary